Concepedia

Sattva S. Neelapu

SS

278

Publications

31.6K

Citations

73

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Moffitt Cancer Center

Stanford University

Dana-Farber Cancer Institute

Mayo Clinic in Arizona

Sattva S. Neelapu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2001–2025

278

Publications

278

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.7K citations · Full text

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke, Armin Ghobadi, Caron A. Jacobson et al. · The Lancet Oncology · 2018 · 2.2K citations

, , +9

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2K citations · Full text

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

Michael Crump, Sattva S. Neelapu, Umar Farooq et al. · Blood · 2017 · 1.6K citations · Full text

Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions

Yeonseok Chung, Shinya Tanaka, Fuliang Chu et al. · Nature Medicine · 2011 · 1.1K citations · Full text

, , +5

Rows per page

1–5 of 278